Mark A. Lones

2.2k total citations
47 papers, 1.5k citations indexed

About

Mark A. Lones is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Mark A. Lones has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 12 papers in Neurology. Recurrent topics in Mark A. Lones's work include Lymphoma Diagnosis and Treatment (33 papers), Viral-associated cancers and disorders (16 papers) and Acute Lymphoblastic Leukemia research (12 papers). Mark A. Lones is often cited by papers focused on Lymphoma Diagnosis and Treatment (33 papers), Viral-associated cancers and disorders (16 papers) and Acute Lymphoblastic Leukemia research (12 papers). Mark A. Lones collaborates with scholars based in United States, United Kingdom and France. Mark A. Lones's co-authors include Sherrie L. Perkins, Mitchell S. Cairo, Richard Sposto, Jonathan Said, Warren G. Sanger, Carl R. Kjeldsberg, Marshall E. Kadin, I. Peter Shintaku, Jonathan L. Finlay and Alfredo Trento and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Mark A. Lones

47 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Lones United States 26 938 652 348 346 222 47 1.5k
Alexander Claviez Germany 26 836 0.9× 751 1.2× 322 0.9× 462 1.3× 441 2.0× 80 2.1k
Georg Mann Austria 13 835 0.9× 397 0.6× 571 1.6× 397 1.1× 205 0.9× 17 1.3k
Mary Gerrard United Kingdom 22 1.2k 1.3× 718 1.1× 536 1.5× 647 1.9× 310 1.4× 52 1.9k
Hirofumi Taji Japan 19 654 0.7× 603 0.9× 125 0.4× 200 0.6× 169 0.8× 35 1.2k
G. Pagnucco Italy 23 565 0.6× 486 0.7× 236 0.7× 138 0.4× 589 2.7× 69 1.4k
J R Anderson United States 13 881 0.9× 603 0.9× 119 0.3× 170 0.5× 261 1.2× 21 1.3k
S B Murphy United States 21 673 0.7× 458 0.7× 1.1k 3.2× 382 1.1× 263 1.2× 32 1.9k
JD Shepherd Canada 18 407 0.4× 394 0.6× 162 0.5× 168 0.5× 228 1.0× 24 1.1k
J M Zucker France 18 446 0.5× 404 0.6× 218 0.6× 608 1.8× 199 0.9× 29 1.7k
Maurizio Musso Italy 19 334 0.4× 364 0.6× 141 0.4× 110 0.3× 243 1.1× 68 1.4k

Countries citing papers authored by Mark A. Lones

Since Specialization
Citations

This map shows the geographic impact of Mark A. Lones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Lones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Lones more than expected).

Fields of papers citing papers by Mark A. Lones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Lones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Lones. The network helps show where Mark A. Lones may publish in the future.

Co-authorship network of co-authors of Mark A. Lones

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Lones. A scholar is included among the top collaborators of Mark A. Lones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Lones. Mark A. Lones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jiehao, Koen van Besien, Attilio Orazi, et al.. (2014). Infectious Disease Pathology. Modern Pathology. 27. 390–394. 12 indexed citations
2.
Said, Jonathan, et al.. (2014). Burkitt Lymphoma and MYC. Advances in Anatomic Pathology. 21(3). 160–165. 8 indexed citations
3.
Smith, Lynette M., James R. Anderson, Minnie Abromowitch, et al.. (2012). The immunophenotype of T ‐lymphoblastic lymphoma in children and adolescents: a C hildren's O ncology G roup report. British Journal of Haematology. 159(4). 454–461. 69 indexed citations
4.
Lones, Mark A., Martine Raphaël, Keith McCarthy, et al.. (2012). Primary Follicular Lymphoma of the Testis in Children and Adolescents. Journal of Pediatric Hematology/Oncology. 34(1). 68–71. 33 indexed citations
5.
Termuhlen, Amanda, Lynette M. Smith, Sherrie L. Perkins, et al.. (2012). Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 59(7). 1229–1233. 31 indexed citations
8.
Miles, Rodney R., Mitchell S. Cairo, Prakash Satwani, et al.. (2007). Immunophenotypic identification of possible therapeutic targets in paediatric non‐Hodgkin lymphomas: a children's oncology group report. British Journal of Haematology. 138(4). 506–512. 11 indexed citations
9.
Lones, Mark A., Martine Raphaël, Sherrie L. Perkins, et al.. (2006). Mature B-Cell Lymphoma in Children and Adolescents. Journal of Pediatric Hematology/Oncology. 28(9). 568–574. 11 indexed citations
10.
Lones, Mark A., Nyla A. Heerema, Michelle M. Le Beau, et al.. (2006). Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08. Cancer Genetics and Cytogenetics. 172(1). 1–11. 39 indexed citations
11.
Lones, Mark A., Warren G. Sanger, Michelle M. Le Beau, et al.. (2004). Chromosome Abnormalities May Correlate With Prognosis in Burkitt/Burkitt-Like Lymphomas of Children and Adolescents. Journal of Pediatric Hematology/Oncology. 26(3). 169–178. 37 indexed citations
12.
Shiramizu, Bruce, Sherrie L. Perkins, Sharon Bergeron, et al.. (2004). Assessing Immunoglobulin Heavy Chain Rearrangements in Pediatric CD20-Positive and CD20-Negative Classic Hodgkin's Diseas. Clinical Lymphoma. 5(3). 184–189. 1 indexed citations
13.
Sabesan, Vani J., Mitchell S. Cairo, Mark A. Lones, et al.. (2003). Assessment of Minimal Residual Disease in Childhood Non-Hodgkin Lymphoma by Polymerase Chain Reaction Using Patient-Specific Primers. Journal of Pediatric Hematology/Oncology. 25(2). 109–113. 14 indexed citations
14.
Cairo, Mitchell S., Richard Sposto, Sherrie L. Perkins, et al.. (2003). Burkitt's and Burkitt‐like lymphoma in children and adolescents: a review of the Children's Cancer Group Experience*. British Journal of Haematology. 120(4). 660–670. 118 indexed citations
15.
Cairo, Mitchell S., Richard Sposto, Anna T. Meadows, et al.. (2002). Childhood and adolescent large‐cell lymphoma (LCL): A review of the children's cancer group experience. American Journal of Hematology. 72(1). 53–63. 30 indexed citations
16.
Lones, Mark A., I. Peter Shintaku, Lawrence M. Weiss, et al.. (1997). Posttransplant lymphoproliferative disorder in liver allograft biopsies: A comparison of three methods for the demonstration of Epstein-Barr virus. Human Pathology. 28(5). 533–539. 28 indexed citations
17.
Khalidi, Hasan S., Mark A. Lones, Yuehua Zhou, Lawrence M. Weiss, & L. Jeffrey Medeiros. (1997). Detection of Epstein-Barr Virus in the L & H Cells of Nodular Lymphocyte Predominance Hodgkin’s Disease:Report of a Case Documented by Immunohistochemical, In Situ Hybridization, and Polymerase Chain Reaction Methods. American Journal of Clinical Pathology. 108(6). 687–692. 16 indexed citations
19.
Swerdlow, Charles D., Dennis D. Reichenbach, Mark A. Lones, et al.. (1995). Anatomical Findings in Patients Having Had a Chronically Indwelling Coronary Sinus Defibrillation Lead. Pacing and Clinical Electrophysiology. 18(11). 2062–2067. 18 indexed citations
20.
Lones, Mark A., Geraldine S. Pinkus, Peter Shintaku, & Jonathan Said. (1994). bcl-2 Oncogene Protein Is Preferentially Expressed in Reed-Sternberg Cells in Hodgkin’s Disease of the Nodular Sclerosis Subtype. American Journal of Clinical Pathology. 102(4). 464–467. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026